AZD8186
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD8186, covering 2019-06-28 to 2023-09-21. Get the full timeline:
Most recent: Clinical Trial Update: PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]